"COVID Vaccine Outreach Declines, Posing Risks for High-Risk Individuals"

This opinion piece discusses the importance of rigorous scientific studies in evaluating the effectiveness of medications and vaccines. The author highlights the example of DayQuil, a popular over-the-counter cold medicine, and emphasizes the need for similar scrutiny when it comes to Covid vaccine boosters. The author argues that the FDA should rely on robust scientific evidence before approving any booster shots, rather than making decisions based on anecdotal reports or political pressure.